Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Common Stock (NQ:NTRB)

6.260 -0.310 (-4.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,016
Open 6.460
Bid (Size) 6.260 (1)
Ask (Size) 6.300 (1)
Prev. Close 6.570
Today's Range 6.210 - 6.700
52wk Range 3.200 - 11.78
Shares Outstanding 6,356,270
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Market Indices Suffer Significant Trend Change Following Friday's Session
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness. 
Via Talk Markets
Topics ETFs Stocks / Equities
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
From Nutriband Inc.
Via GlobeNewswire

Performance

YTD
+37.5%
+37.5%
1 Month
-15.3%
-15.3%
3 Month
+62.6%
+62.6%
6 Month
+4.2%
+4.2%
1 Year
+38.5%
+38.5%

More News

Read More
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
Via ACCESSWIRE
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
From Nutriband Inc.
Via GlobeNewswire
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
From Nutriband Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
On Friday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Nutriband Issues Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th
From Nutriband Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
Via ACCESSWIRE
Are Pharma Stocks Harmful To Your Financial Health ?
Via Talk Markets
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A Session
Via Investor Brand Network
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
Via ACCESSWIRE
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
Via FinancialNewsMedia
Exposures Product Safety
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
From FN Media Group LLC
Via GlobeNewswire
NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
Via ACCESSWIRE
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product
Via Investor Brand Network

Frequently Asked Questions

Is Nutriband Inc. - Common Stock publicly traded?
Yes, Nutriband Inc. - Common Stock is publicly traded.
What exchange does Nutriband Inc. - Common Stock trade on?
Nutriband Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nutriband Inc. - Common Stock?
The ticker symbol for Nutriband Inc. - Common Stock is NTRB on the Nasdaq Stock Market
What is the current price of Nutriband Inc. - Common Stock?
The current price of Nutriband Inc. - Common Stock is 6.260
When was Nutriband Inc. - Common Stock last traded?
The last trade of Nutriband Inc. - Common Stock was at 03/28/25 04:00 PM ET
What is the market capitalization of Nutriband Inc. - Common Stock?
The market capitalization of Nutriband Inc. - Common Stock is 39.79M
How many shares of Nutriband Inc. - Common Stock are outstanding?
Nutriband Inc. - Common Stock has 40M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.